Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate

Arthritis and Rheumatism

Volumn 41, Issue 6, 1998, Pages 1019-1025

  Guerassimov, Alexei ^a,e   Zhang, Yiping ^a   Banerjee, Subhashis ^a   Cartman, Annie ^b   Leroux, Jean Yves ^b   Rosenberg, Lawrence C ^c   Esdaile, John ^d   Fitzcharles, Mary Ann ^e   Poole, A Robin ^e  

^a BASF Bioresearch Corporation   (United States)

^b SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d Mary Pack Arthritis Centre   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; KERATAN SULFATE; PROTEINASE; PROTEOGLYCAN;

ADULT; AGED; ANTIGEN RECOGNITION; ARTICLE; ARTICULAR CARTILAGE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; NONARTICULAR RHEUMATISM; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; POLYARTHRITIS; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; AGGRECANS; ANIMALS; ARTHRITIS, RHEUMATOID; CATTLE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNITY, CELLULAR; KERATAN SULFATE; LECTINS, C-TYPE; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEOGLYCANS; REFERENCE VALUES;

EID: 0031799179     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199806)41:6<1019::AID-ART8>3.0.CO;2-X     Document Type: Article

References (40)

1. Poole AR, Mathai L, Buzás E, Dayer E. Autoimmunity to cartilage proteoglycans in human and animal inflammatory joint disease. In: Lewis AJ, Doherty NS, Ackerman VR, editors. Therapeutic approaches to inflammatory disease. Amsterdam: Elsevier; 1989. p. 76-83.
2. Poole AR. Immunology of cartilage. In: Moskowitz RW, Howell DS, Goldherg VM, Mankin HJ, editors. Osteoarthritis diagnosis and medical/surgical management. 2nd ed. Philadelphia: WB Saunders; 1992. p. 155-89.
3. Poole AR, Cartilage in health and disease. In: McCarty DJ, Koopman WJ, editors. Arthritis and allied conditions. 12th ed. Philadelphia: Lea and Febiger; 1993. p. 279-333.
4. Boissier M-C, Chiocchia G, Rouziere M-C, Herbage D, Fournier C. Arthritogenicity of minor cartilage collagens (types IX and XI) in mice. Arthritis Rheum 1990;33:1-8.
5. Karopoulos C, Rowley MJ, Handley C. Intrasynovial levels of sulphated glycosaminoglycans and autoantibodies to type II collagen in rheumatoid arthritis: a correlative analysis. Rheumatol Int 1993;13:15-20.
6. Golds EE, Poole AR. Connective tissue antigens stimulate collagenase production in arthritic diseases. Cell Immunol 1984;86: 190-205.
7. Verheijden GFM, Rijnders AWM, Bos E, Coenen-de Roo CJJ, van Staveren CJ, Miltenburg AMM, et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum 1997;40:1115-25.
8. Barry FP, Rosenberg LC, Gaw JU, Gaw JU, Koob TJ, Neame PJ. N-and O-linked keratan sulfate on the hyaluronan binding region of aggrecan from mature and immature bovine cartilage. J Biol Chem 1995;270:20516-24.
9. Heinegård D, Axelsson I. Distribution of keratan sulfate in cartilage proteoglycans. J Biol Chem 1977;252:1971-9.
10. Fosang AJ, Hardingham TE. Isolation of the N-terminal globular protein domains from cartilage proteoglycans: identification of G2 domain and its lack of interaction with hyaluronate and link protein. Biochem J 1989;261:801-9.
11. Glant TT, Mikecz K, Roughley PJ, Buzás E, Poole AR. Agerelated changes in protein-related epitopes of human articular cartilage proteoglycans. Biochem J 1986;236:71-5.
12. Roughley PJ, White RT. Age related changes in the structures of the proteoglycan subunits from human articular cartilage. J Biol Chem 1980;225:217-24.
13. Yoo JU, Kresina TF, Malemud CJ, Goldberg VM. Epitopes of proteoglycans eliciting an anti-proteoglycan response in chronic immune synovitis. Proc Natl Acad Sci U S A 1987;84:832-6.
14. Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in BALB/c mice: clinical features and histopathology. Arthritis Rheum 1987;30:201-12.
15. Mikecz K, Glant TT, Buzás E, Poole AR. Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (non-immunized) BALB/c mice. Arthritis Rheum 1990;33:866-76.
16. Holmdahl R, Klareskog L, Rubin K, Larsson E, Wigzell H. T lymphocytes in collagen II-induced arthritis in mice: characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol 1985;22:295-306.
17. Buzás EI, Brennan FR, Mikecz K, Garzó M, Negroiu G, Holló K, et al. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice. J Immunol 1995;155:2679-87.
18. Mikecz K, Glant TT, Poole AR. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum 1987;30:306-18.
19. Leroux J-Y, Guerassimov A, Cartman A, Delaunay N, Webber C, Rosbenberg LC, et al. Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo. J Clin Invest 1996;97:621-32.
20. Guerassimov A, Delaunay N, Banerjee S, Leroux J-Y, Cartman A, Rosenberg LC, et al. Immunity to cartilage link protein can induce an erosive polyarthritis in BALB/c mice [abstract]. Arthritis Rheum 1994;37 Suppl 9:S397.
21. Guerassimov A, Webber C, Delaunay N, Cartman A, Fitzcharles M-A, Esdaile J, et al. Cellular immune responses to cartilage link protein in patients with rheumatoid arthritis and ankylosing spondylitis [abstract]. Arthritis Rheum 1995;38 Suppl 9:S159.
22. Doran MC, Goodstone NJ, Hobbs RN, Ashton BA. Cellular immunity to cartilage link protein in patients with inflammatory arthritis and non-arthritic controls. Ann Rheum Dis 1995;54:466-70.
23. Guerassimov A, Duffy C, Zhang Y, Banerjee S, Leroux J-Y, Reimann A, et al. Immunity to cartilage link protein in patients with juvenile rheumatoid arthritis. J Rheumatol 1997;24:959-64.
24. Karopoulos C, Rowley MJ, Ilic MZ, Handley CJ. Presence of antibodies to native G1 domain of aggrecan core protein in synovial fluids from patients with various joint diseases. Arthritis Rheum 1996;39:1990-7.
25. Guerassimov A, Zhang Y, Rosenberg LC, Fitzcharles M-A, Esdaile J, Poole AR. Cellular immune responses to the G1 globular domain of the cartilage proteoglycan aggrecan in patients with rheumatoid arthritis [abstract]. Arthritis Research Conference; 1997; Bethesda, MD.
26. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
27. Leroux J-Y, Poole AR, Webber C, Vipparti V, Choi HK, Rosenberg LC, et al. Characterization of proteoglycan-reactive T cell line and hybridomas from mice with proteoglycan-induced arthritis. J Immunol 1992;148:2090-6.
28. Tank LH, Rosenberg LC, Reiner A, Poole AR. Proteoglycan from bovine nasal cartilage: properties of a soluble form of link protein. J Biol Chem 1979;254:10523-31.
29. Stevens JW, Oike Y, Handley C, Hascall VC, Hampton A, Caterson B. Characteristics of the core protein of the aggregating proteoglycan from the Swarm rat chondrosarcoma. J Cell Biochem 1984;26:247-59.
30. Poole AR, Webber C, Reiner A, Roughley P. Studies of a monoclonal antibody to skeletal keratan sulphate: importance of antibody valency. Biochem J 1989;260:849-56.
31. Neame PJ, Christner JE, Baker JR. Cartilage proteoglycan aggregates: the link protein and proteoglycan amino-terminal globular domains have similar structures. J Biol Chem 1987;262:17768-78.
32. Hamerman D. Cartilage changes in the rheumatoid joint. Clin Orthop 1969;64:91-7.
33. Witter J, Roughley PJ, Webber C, Roberts N, Keystone E, Poole AR. The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis. Arthritis Rheum 1987;30:519-29.
34. Hughes CE, Caterson B, Fosang AJ, Roughley PJ, Mort JS. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem J 1995;305:799-804.
35. Roughley PJ, White RJ, Poole AR. Identification of a hyaluronic acid-binding protein that interferes with the preparation of high-buoyant-density proteoglycan aggregates from adult human articular cartilage. Biochem J 1985;231:129-38.
36. Saxne T, Heinegård D. Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions. Arthritis Rheum 1992;35:385-90.
37. Edge ASB, Faltynek CR, Hof L, Reichert LE, Weber P. Deglycosylation of glycoproteins by trifluoromethanesulphonic acid. Anal Biochem 1981;118:131-7.
38. Goodstone NJ, Doran MC, Hobbs RN, Butler RC, Dixey JJ, Ashton BA. Cellular immunity to cartilage aggrecan core protein in patients with rheumatoid arthritis and non-arthritic controls. 1996;55:40-6.
39. Ishioka GY, Lamont AG, Thomson D, Bulbow N, Gaeta FCA, Sette A, et al. MHC interaction and T cell recognition of carbohydrates and glycopeptides. J Immunol 1992;148:2446-51.
40. Olden K, Pratt RM, Yamada KM. Role of carbohydrate in biological function of the adhesive glycoproteinase fibronectin. Proc Natl Acad Sci U S A 1979;76:3343-7.